Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cathepsin B and L inhibitors claimed by Canadian researchers

June 26, 1998

Sibia Neurosciences initiates phase I trial with SIB-1553A

June 26, 1998

Selective 5-HT1F agonists claimed to be particularly useful for migraine, chronic pain

June 25, 1998

Zeldox deemed nonapprovable by the FDA

June 24, 1998

Duract withdrawn from the U.S. market due to reports of hepatotoxicity

June 24, 1998

Aspirin improves MS-related fatigue

June 24, 1998

Anseculin continues in phase II after successful testing in older volunteers

June 24, 1998

Clozapine therapy results in increased leptin levels

June 23, 1998

Integra LifeSciences to begin phase II clinical trials for Peripheral Nerve Regeneration Conduit

June 23, 1998

ABT-594, a potent analgesic with improved safety in preclinical models

June 22, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...